2021
An Interdisciplinary Approach to Metastatic Pancreatic Cancer and Comorbid Opioid Use Disorder Treatment Within a VA Health Care System.
Ruskin A, Falker CG, Edens EL, Bauer MR. An Interdisciplinary Approach to Metastatic Pancreatic Cancer and Comorbid Opioid Use Disorder Treatment Within a VA Health Care System. Federal Practitioner 2021, 38: s66-s71. PMID: 34733097, PMCID: PMC8560123, DOI: 10.12788/fp.0160.Peer-Reviewed Original ResearchPancreatic cancerOpioid use disorder treatmentVA health care systemActive substance use disorderAdvanced pancreatic cancerMetastatic pancreatic cancerUse disorder treatmentSubstance use disordersHealth care systemUse disordersDisorder treatmentCancer treatmentCare systemMultidisciplinary approachCancerTreatmentPatients
2018
Co-occurring Substance and Mental Health Disorders
Jorandby-Quinones L, Edens E, Rosenheck R. Co-occurring Substance and Mental Health Disorders. 2018, 307-333. DOI: 10.1007/978-1-4939-7438-2_20.ChaptersDual diagnosisMental health care deliveryHigh treatment burdenMore medical conditionsMental health care systemMental health disordersSubstance use disordersCo-occurring substanceEvolution of treatmentHealthcare delivery approachHealth care deliveryHealth care systemTreatment burdenMedical conditionsUse disordersHealth disordersMedical carePatientsCare deliveryPsychosocial conditionsIndividual diseasesCare systemDiagnosisTreatmentDisease
2014
Pilot results of a new model of addiction treatment: managing addiction as a chronic disease.
Edens EL, Donahue CA, Riordan CE. Pilot results of a new model of addiction treatment: managing addiction as a chronic disease. Connecticut Medicine 2014, 78: 487-91. PMID: 25314889.Peer-Reviewed Original ResearchConceptsSubstance use disordersAddiction treatmentChronic diseasesDSM-5 substance use disordersMonths of treatmentConcept pilot studyOutpatient addiction treatmentRandom alcoholAddiction treatment systemPilot resultsSustained abstinenceUse disordersIllness modelPilot studyDrug testsResidential careCarePilot participantsDay programTreatmentCurrent standardDiseasePotential effectivenessParticipantsAddiction
2013
Mecamylamine for Treatment of People With Dual Diagnoses of Depression and Alcohol Dependence
Ralevski E, Jane J, O’Brien E, Edens E, Arnaout B, Kerfoot K, Keegan K, Weiner J, Russo M, Petrakis I. Mecamylamine for Treatment of People With Dual Diagnoses of Depression and Alcohol Dependence. Journal Of Dual Diagnosis 2013, 9: 301-310. DOI: 10.1080/15504263.2013.835163.Peer-Reviewed Original ResearchDepressive symptomsAlcohol dependenceDual diagnosisRates of smokingMain outcome variablesSymptoms of depressionTreatment of peopleTreatment trialsComorbid depressionMecamylamineSide effectsNonsmokersSmokingSymptomsOutcome variablesBest treatmentDrinking outcomesDepressionPlaceboSmokersFurther studiesSignificant differencesDiagnosisParticipantsTreatment
2009
Novel Pharmacological Approaches to Drug Abuse Treatment
Edens E, Massa A, Petrakis I. Novel Pharmacological Approaches to Drug Abuse Treatment. Current Topics In Behavioral Neurosciences 2009, 3: 343-386. PMID: 21161760, DOI: 10.1007/7854_2009_29.Peer-Reviewed Original ResearchConceptsNovel pharmacological approachesPharmacological approachesAddiction treatmentDrug abuse treatmentDrugs of abuseWithdrawal discomfortDopaminergic tonePharmacologic researchRewarding effectsNeural pathwaysAbuse treatmentNeurobiological underpinningsTreatmentNicotineDrugsVaried treatmentsAdditional substancesComorbiditiesMedicationsOpiates